Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary of Abstracts. 2013 Authors' conclusions One systematic review regarding the effectiveness and safety of gentamicin treatment administered via bladder instillation for the treatment of recurrent urinary tract infections was identified. No relevant comparative studies or evidence-based guidelines were identified. Indexing Status Subject indexing assigned by CRD MeSH Gentamicinss; Recurrence; Urinary Tract Infections Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32014000869 Date abstract record published 17/07/2014 |